165 related articles for article (PubMed ID: 20977417)
1. 3D QSAR of aminophenyl benzamide derivatives as histone deacetylase inhibitors.
Mahipal ; Tanwar OP; Karthikeyan C; Moorthy NS; Trivedi P
Med Chem; 2010 Sep; 6(5):277-85. PubMed ID: 20977417
[TBL] [Abstract][Full Text] [Related]
2. 3D QSAR and docking study of gliptin derivatives as DPP-IV inhibitors.
Agrawal R; Jain P; Dikshit SN; Bahare RS
Comb Chem High Throughput Screen; 2013 May; 16(4):249-73. PubMed ID: 23305140
[TBL] [Abstract][Full Text] [Related]
3. 3D QSAR and docking studies of various amido and benzyl-substituted 3-amino-4-(2-cyanopyrrolidide)pyrrolidinyl analogs as DPP-IV inhibitors.
Agrawal R; Jain P; Dikshit SN; Jain S
Protein Pept Lett; 2013 Sep; 20(9):1066-78. PubMed ID: 23607811
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
Tripathy S; Azam MA; Jupudi S; Sahu SK
J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
[TBL] [Abstract][Full Text] [Related]
5. Computational identification of novel histone deacetylase inhibitors by docking based QSAR.
Nair SB; Teli MK; Pradeep H; Rajanikant GK
Comput Biol Med; 2012 Jun; 42(6):697-705. PubMed ID: 22521374
[TBL] [Abstract][Full Text] [Related]
6. Pharmacophore generation and atom-based 3D-QSAR of novel quinoline-3-carbonitrile derivatives as Tpl2 kinase inhibitors.
Teli MK; Rajanikant GK
J Enzyme Inhib Med Chem; 2012 Aug; 27(4):558-70. PubMed ID: 21851209
[TBL] [Abstract][Full Text] [Related]
7. 3D-QSAR (CoMFA, CoMSIA) and Molecular Docking Studies on Histone Deacetylase 1 Selective Inhibitors.
Abdizadeh T; Ghodsi R; Hadizadeh F
Recent Pat Anticancer Drug Discov; 2017 Nov; 12(4):365-383. PubMed ID: 28482791
[TBL] [Abstract][Full Text] [Related]
8. Pharmacophore Based 3D-QSAR, Virtual Screening and Docking Studies on Novel Series of HDAC Inhibitors with Thiophen Linker as Anticancer Agents.
Patel P; Singh A; Patel VK; Jain DK; Veerasamy R; Rajak H
Comb Chem High Throughput Screen; 2016; 19(9):735-751. PubMed ID: 27487787
[TBL] [Abstract][Full Text] [Related]
9. Computer-Driven Development of an in Silico Tool for Finding Selective Histone Deacetylase 1 Inhibitors.
Sirous H; Campiani G; Brogi S; Calderone V; Chemi G
Molecules; 2020 Apr; 25(8):. PubMed ID: 32331470
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, 3D pharmacophore, QSAR, and docking studies of carboxylic acid derivatives as Histone Deacetylase inhibitors and cytotoxic agents.
Abdel-Atty MM; Farag NA; Kassab SE; Serya RAT; Abouzid KAM
Bioorg Chem; 2014 Dec; 57():65-82. PubMed ID: 25233258
[TBL] [Abstract][Full Text] [Related]
11. Pharmacophore generation and atom-based 3D-QSAR of N-iso-propyl pyrrole-based derivatives as HMG-CoA reductase inhibitors.
Teli MK; K RG
Org Med Chem Lett; 2012 Jul; 2(1):25. PubMed ID: 22747771
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and evaluation of novel N-hydroxybenzamides/N-hydroxypropenamides incorporating quinazolin-4(3H)-ones as histone deacetylase inhibitors and antitumor agents.
Hieu DT; Anh DT; Tuan NM; Hai PT; Huong LT; Kim J; Kang JS; Vu TK; Dung PTP; Han SB; Nam NH; Hoa ND
Bioorg Chem; 2018 Feb; 76():258-267. PubMed ID: 29223029
[TBL] [Abstract][Full Text] [Related]
13. HDAC3 is a potential validated target for cancer: An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approaches.
Adhikari N; Amin SA; Trivedi P; Jha T; Ghosh B
Eur J Med Chem; 2018 Sep; 157():1127-1142. PubMed ID: 30179749
[TBL] [Abstract][Full Text] [Related]
14. Pharmacophore modeling, 3D-QSAR, and in silico ADME prediction of N-pyridyl and pyrimidine benzamides as potent antiepileptic agents.
Malik R; Mehta P; Srivastava S; Choudhary BS; Sharma M
J Recept Signal Transduct Res; 2017 Jun; 37(3):259-266. PubMed ID: 27607834
[TBL] [Abstract][Full Text] [Related]
15. Identification of 3-Nitro-2,4,6-trihydroxybenzamide Derivatives as Photosynthetic Electron Transport Inhibitors by QSAR and Pharmacophore Studies.
Sharma MC
Interdiscip Sci; 2016 Jun; 8(2):109-21. PubMed ID: 26245276
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and docking studies on benzamide derivatives as histone deacetylase inhibitors.
Lu A; Luo H; Shi M; Wu G; Yuan Y; Liu J; Tang F
Bioorg Med Chem Lett; 2011 Aug; 21(16):4924-7. PubMed ID: 21741834
[TBL] [Abstract][Full Text] [Related]
17. Combined pharmacophore modeling, 3D-QSAR and docking studies to identify novel HDAC inhibitors using drug repurposing.
Liu J; Zhu Y; He Y; Zhu H; Gao Y; Li Z; Zhu J; Sun X; Fang F; Wen H; Li W
J Biomol Struct Dyn; 2020 Feb; 38(2):533-547. PubMed ID: 30938574
[TBL] [Abstract][Full Text] [Related]
18. Fragment based G-QSAR and molecular dynamics based mechanistic simulations into hydroxamic-based HDAC inhibitors against spinocerebellar ataxia.
Sinha S; Tyagi C; Goyal S; Jamal S; Somvanshi P; Grover A
J Biomol Struct Dyn; 2016 Oct; 34(10):2281-95. PubMed ID: 26510381
[TBL] [Abstract][Full Text] [Related]
19. Pharmacophore filtering and 3D-QSAR in the discovery of new JAK2 inhibitors.
Dhanachandra Singh Kh; Karthikeyan M; Kirubakaran P; Nagamani S
J Mol Graph Model; 2011 Sep; 30():186-97. PubMed ID: 21831680
[TBL] [Abstract][Full Text] [Related]
20. Novel aminophenyl benzamide-type histone deacetylase inhibitors with enhanced potency and selectivity.
Moradei OM; Mallais TC; Frechette S; Paquin I; Tessier PE; Leit SM; Fournel M; Bonfils C; Trachy-Bourget MC; Liu J; Yan TP; Lu AH; Rahil J; Wang J; Lefebvre S; Li Z; Vaisburg AF; Besterman JM
J Med Chem; 2007 Nov; 50(23):5543-6. PubMed ID: 17941625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
